Search results
Results From The WOW.Com Content Network
'brain'; and the medical suffix -itis, "inflammation"), also known as herpes meningoencephalitis, is a medical condition that simultaneously resembles both meningitis, which is an infection or inflammation of the meninges, and encephalitis, which is an infection or inflammation of the brain tissue.
Meningococcal meningitis is a form of bacterial meningitis. Meningitis is a disease caused by inflammation and irritation of the meninges, the membranes surrounding the brain and spinal cord. In meningococcal meningitis this is caused by the bacteria invading the cerebrospinal fluid and circulating through the central nervous system. Sub ...
In adults, too, meningococcal meningitis has a lower mortality (3–7%) than pneumococcal disease. [ 3 ] In children there are several potential disabilities which may result from damage to the nervous system, including sensorineural hearing loss , epilepsy , learning and behavioral difficulties, as well as decreased intelligence . [ 2 ]
St. Louis encephalitis; Slow virus infections, which include: Acquired immunodeficiency syndrome (AIDS) Subacute sclerosing panencephalitis by Measles virus; Progressive multifocal leukoencephalopathy; Rabies; Tick-borne encephalitis; Varicella; Viral encephalitis lists 37 causes; Viral meningitis; Western equine encephalitis
Encephalitis with meningitis is known as meningoencephalitis, while encephalitis with involvement of the spinal cord is known as encephalomyelitis. [ 2 ] The word is from Ancient Greek ἐγκέφαλος , enképhalos 'brain', [ 37 ] composed of ἐν , en , 'in' and κεφαλή , kephalé , 'head', and the medical suffix -itis 'inflammation'.
Pneumococcal disease, meningococcal disease, tick-borne encephalitis. COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands.
A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine licensed for people older than 55. MPSV4 may be used in people 2–55 years old if the MCV4 vaccines are not available or contraindicated. Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first ...
Pneumococcal disease, meningococcal disease, tick-borne encephalitis. COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands.